Kim Theilgaard-Mønch
Clinical Associate Professor, Group leader
Department of Clinical Medicine
Blegdamsvej 9, 2100 København Ø
Theilgaard Group
Ole Maaløes Vej 5
2200 København N.
Member of:
- 2022
- Published
Effects of chemotherapy dose reductions in overweight patients with acute myeloid leukaemia: A Danish nationwide cohort study
Kristensen, D. T., Nielsen, L. B., Jakobsen, L. H. K., Kristensen, T. C., Jepsen, L. Ø., Schöllkopf, C., Theilgaard-Mønch, Kim, El-Galaly, T. C., Roug, A. S. & Severinsen, M. T., 2022, In: British Journal of Haematology. 199, p. 539-548 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Inhibition of oxidized nucleotide sanitation by TH1579 and conventional chemotherapy cooperatively enhance oxidative DNA-damage and survival in AML
Centio, A., Estruch Alrich, Montserrat, Reckzeh, K., Sanjiv, K., Vittori, Camilla, Engelhard, Sophia Manon Charlotte, Warpman Berglund, U., Helleday, T. & Theilgaard-Mønch, Kim, 2022, In: Molecular Cancer Therapeutics. p. 703-714Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Phosphorylation of SHP2 at Tyr62 enables acquired resistance to SHP2 allosteric inhibitors in FLT3-ITD-driven AML
Pfeiffer, A., Franciosa, Giulia, Locard-Paulet, Marie, Piga, I., Reckzeh, K., Vemulapalli, V., Blacklow, S. C., Theilgaard-Mønch, Kim, Jensen, Lars Juhl & Olsen, Jesper Velgaard, 2022, In: Cancer Research. 82, 11, p. 2141-2155 15 p.Research output: Contribution to journal › Journal article › Research › peer-review
Psychotropic Drug Use in Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndrome (MDS): A Danish Nationwide Matched Cohort Study of 2404 AML and 1307 MDS Patients
Jensen, O., Øvlisen, A. K., Jakobsen, L. H., Roug, A. S., Nielsen, R. E., Marcher, C. W., Ebbesen, L. H., Theilgaard-Mønch, Kim, Møller, P., Schöllkopf, C., Torp-Pedersen, Christian, El-Galaly, T. C. & Severinsen, M. T., 2022, In: Clinical Epidemiology. 14, p. 225-237 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
TET2 deficiency cooperates with CBFB-MYH11 to induce acute myeloid leukaemia and represents an early leukaemogenic event
Reckzeh, K., Estruch Alrich, Montserrat, Ali, M., Helbo, A. S., Mosbech, A., Won, K. J., Rücker, F., Döhner, K. & Theilgaard-Mønch, Kim, 2022, In: British Journal of Haematology. 197, 2, p. 201-206Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Transcription factor-driven coordination of cell cycle exit and lineage-specification in vivo during granulocytic differentiation: In memoriam Professor Niels Borregaard
Theilgaard-Mønch, Kim, Pundhir, Sachin, Reckzeh, K., Su, Jinyu, Tapia, Marta Cecylia, Furtwängler, Benjamin, Jendholm, J., Jakobsen, J. S., Hasemann, M. S., Knudsen, K. J., Cowland, J. B., Fossum, A., Schoof, E., Schuster, Mikkel Bruhn & Porse, Bo Torben, 2022, In: Nature Communications. 13, 1, 17 p., 3595.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 3997971
Most downloads
-
2501
downloads
HemaExplorer: a database of mRNA expression profiles in normal and malignant haematopoiesis
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
80
downloads
Mutant CEBPA directly drives the expression of the targetable tumor-promoting factor CD73 in AML
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
39
downloads
Phosphorylation of SHP2 at Tyr62 enables acquired resistance to SHP2 allosteric inhibitors in FLT3-ITD-driven AML
Research output: Contribution to journal › Journal article › Research › peer-review
Published